OpenVSafe by OpenVAERS
Search V-safe

VED-18731-70869

3 vaccinations 8 coded responses 19 check-ins 7 free-text entries 0 call cases
Sex
Male
Age at first dose
0-4
ZIP prefix
074 / NJ
Registered
2022-08-07
Relationship
Child or adolescent in my care
Guardian
CN7-18947-48704
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2022-07-29
    Dose 1 — Pfizer-BioNTech
  2. 2022-08-07
    Registered in v-safe
  3. 2022-08-07
    Health check-in — day 7, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  4. 2022-08-13
    Survey response — day 14, dose 1, dependent
    MedDRA: Cough, Eyelid margin crusting, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Runny nose, cough, crusty eyes
    MedDRA releases: 2024-11 · check-in free text available
  5. 2022-08-19
    Dose 2 — Pfizer-BioNTech
  6. 2022-08-24
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  7. 2022-08-25
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2022-08-26
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · Diarrhea
    Adult check-in
  9. 2022-09-02
    Health check-in — day 14, dose 2, dependent
    Feeling: Fair
    Adult check-in
  10. 2022-09-10
    Survey response — day 21, dose 2, dependent
    MedDRA: Eczema, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Eczema flare up
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-09-16
    Survey response — day 28, dose 2, dependent
    MedDRA: Lower respiratory tract infection, Nightmare, Productive cough — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Chest cold with phlegm and nightmares
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-09-23
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  13. 2022-10-01
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  14. 2022-10-21
    Dose 3 — Pfizer-BioNTech
  15. 2022-10-22
    Survey response — days 1–6 daily, dose 3, dependent
    MedDRA: Feeling abnormal — Feeling: Fair · Site: Pain · Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Free text: Out of it
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-10-24
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  17. 2022-10-25
    Survey response — days 1–6 daily, dose 3, dependent
    MedDRA: Pruritus — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Itchy
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-10-26
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  19. 2022-10-28
    Survey response — day 7, dose 3, dependent
    MedDRA: Decreased appetite — Feeling: Fair
    Free text: No appetite
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-11-04
    Health check-in — day 14, dose 3, dependent
    Feeling: Fair
    Adult check-in
  21. 2022-11-11
    Survey response — day 21, dose 3, dependent
    MedDRA: Lower respiratory tract infection, Nasal congestion — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Stuffy nose and chest cold
    MedDRA releases: 2024-11 · check-in free text available
  22. 2023-01-20
    Survey response — 3 months, dose 3, dependent
    MedDRA: Cough, Malaise, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activities
    MedDRA releases: 2024-11
  23. 2023-04-21

Vaccinations

DoseDateManufacturerCo-administered
12022-07-29Pfizer-BioNTech No
22022-08-19Pfizer-BioNTech No
32022-10-21Pfizer-BioNTech No

Free text

Release 12 — day 14, dose 1, dependent

2022-08-13

Symptoms: Runny nose, cough, crusty eyes

Release 12 — day 21, dose 2, dependent

2022-09-10

Symptoms: Eczema flare up

Release 12 — day 28, dose 2, dependent

2022-09-16

Symptoms: Chest cold with phlegm and nightmares

Release 12 — days 1–6 daily, dose 3, dependent

2022-10-22

Systemic reaction (other): Out of it

2022-10-25

Systemic reaction (other): Itchy

Release 12 — day 7, dose 3, dependent

2022-10-28

Systemic reaction (other): No appetite

Release 12 — day 21, dose 3, dependent

2022-11-11

Symptoms: Stuffy nose and chest cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDEczema · · ✓
SDEyelid margin crusting · · ✓
SDLower respiratory tract infection · · ✓
SDMalaise · · ✓
SDNasal congestion · · ✓
SDNightmare · · ✓
SDPre-existing disease · · ✓
SDProductive cough · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓
SRODecreased appetite · · ✓
SROFeeling abnormal · · ✓
SROPruritus · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release